Macrophages from IL-12p40-deficient mice have a bias toward the M2 activation profile

Journal of Leukocyte Biology

Volumn 71, Issue 2, 2002, Pages 271-278

  Bastos, Karina R B ^a,b   Alvarez, José M ^a,b   Marinho, Cláudio R F ^a,b   Rizzo, Luiz V ^a,b   Lima, Maria Regina D'Império ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital de Transplante E J Zerbini   (Brazil)

Author keywords

IL 12p40KO; Macrophage polarization; Nitric oxide; TGF 1; Trypanosoma cruzi

Indexed keywords

INTERLEUKIN 12; NITRIC OXIDE; PROTEIN P40; RECOMBINANT GAMMA INTERFERON; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; TH1 CELL; TRYPANOSOMA CRUZI;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION; INTERFERON-GAMMA, RECOMBINANT; INTERLEUKIN-12; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; MICE, KNOCKOUT; NITRIC OXIDE; TRANSFORMING GROWTH FACTOR BETA; TRYPANOSOMA CRUZI; UP-REGULATION;

ANIMALIA; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0036486831     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Kobayashi M., Fitz, L., Ryan, M., Hewick, R. M., Clark, S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B., Trinchieri, G. (1989) Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J. Exp. Med. 170, 827-845.
2. Gubler, U., Chua, A. O., Schoenhaut, D. S., Dwyer, C. M., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A. G., Quinn, P. M., Familletti, P. C., Gately, M. K. (1991). Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl. Acad. Sci. USA 88, 4143-4147.
3. Heufler, C., Koch, F., Stanzl, U., Topar, G., Wysocka, M., Trinchieri G., Enk A., Steimnan, R. M., Romani, N., Schuler, G. (1996) Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26, 659-668.
4. D'Andrea, A., Rengaraju, M., Valiante, N. M., Chehimi, J., Kubin, M., Aste, M., Chan, S. H., Kobayashi, M., Young, D., Nickbarg, E. (1992) Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J. Exp. Med. 176, 1387-1398.
5. Oppmann, B., Lesley, R., Blom, B., Timans, J. C., Xu, Y., Hunte, B., Vega, F., Yu, N., Wang, J., Singh, K., Zonin, F., Vaisberg, E., Churakova, T., Liu, M-R., Gorman, D., Wagner, J., Zurawski, S., Liu, Y-J., Abrams, J. S., Moore, K. W., Rennick, D., de Waal-Malefyt, R., Hannum, C., Bazan, J. F., Kastelein, R. A. (2000) Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity 13, 715-725.
6. Wiekowski, M. T., Leach, M. W., Evans, E. W., Sullivan, L., Chen,. S-C., Vassileva, G., Bazan, J. F., Gorman, D. M., Kastelein, R. A., Narula, S., Lira, S. A. (2001) Ubiquitous transgenic expression of the IL-23 subunit p19 induces multiorgan inflammation, runting, infertility, and premature death. J. Immunol. 166, 7563-7570.
7. + cell-mediated protective immunity against herpes simplex virus-2 challenge. J. Immunol. 162, 2912-2921.
8. Stobie, L., Gurunathan, S., Prussin, C., Sacks, D. L., Glaichenhaus, N., Wu, C. Y., Seder, R. A. (2000). The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasite challenge. Proc. Natl. Acad. Sci. USA 97, 8427-8432.
9. Germann, T., Bongartz, M., Dlugonska, H., Hess, H., Schmitt, E., Kolbe, L., Kolsch, E., Podlaski, F. J., Gately, M. K., Rude, E. (1995). Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur. J. Immunol. 25, 823-829.
10. Heinzel, F. P., Schoenhaut, D. S., Rerko, R. M., Rosser, L. E., Gately, M. K. (1993) Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177, 1505-1509.
11. Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S., Sher, A. (1993) Interleukin 12 is required for the T-lymphocyte-independent induction of interferon by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90, 6115-6119.
12. Meko, J. B., Yim, J. H., Tsung, K., Norton, J. A. (1995). High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12. Cancer Res. 55, 4765-4770.
13. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., Gately, M. K. (1996) IL-12-deficient mice are defective in IFN gamma production and type 1 cytokine responses. Immunity 4, 471-481.
14. Mattner, F., Magram, J., Ferrante, J., Launois, P., Di Padova, K., Behin, R., Gately, M. K., Louis, J. A., Alber, G. (1996) Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26, 1553-1559.
15. Cooper, A. M., Magram, J., Ferrante, J., Orme, I. M. (1997) Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis. J. Exp. Med. 186, 39-45.
16. Trinchieri, G. (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13, 251-276.
17. Trinchieri, G. (1997) Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma). Curr. Opin. Immunol. 9, 17-23.
18. Puddu, P., Fantuzzi, L., Borghi, P., Varano, B., Rainaldi, G., Guillemard, E., Malorni, W., Nicaise, P., Wolf, S. F., Belardelli, F., Gessani, S. (1997) IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J. Immunol. 159, 3490-3497.
19. Fenton, M., Vermeulen, M. W., Kim, S., Burdick, M., Strieter, R. M., Kornfield, H. (1997) Induction of interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65, 5149-5156.
20. Munder, M., Mallo, M., Eichmann, K., Modolell, M. (1998) Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187, 2103-2108.
21. Salkowski, C. A., Kopydlowski, K., Blanco, J., Cody, M. J., McNally, R., Vogel, S. N. (1999) IL-12 is dysregulated in macrophages from IRF-1 and IRF-2 knockout mice. J. Immunol. 163, 1529-1536.
22. Wang, J., Wakeham, J., Harkness, R., Xing, Z. (1999) Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Investig. 103, 1023-1029.
23. + lymphoid dendritic cells. J. Exp. Med. 189, 1981-1986.
24. Fantuzzi, L., Puddu, P., Varano, B., Del Corno, M., Belardelli, F., Gessani, S. (2000) IFN-alpha and IL-18 exert opposite regulatory effects on the IL-12 receptor expression and IL-12-induced IFN-gamma production in mouse macrophages: novel pathways in the regulation of the inflammatory response of macrophages. J. Leukoc. Biol. 68, 707-714.
25. Xing, Z., Zganiacz, A., Santosuosso, M. (2000) Role of IL-12 in macrophage activation during intracellular infection: IL-12 and mycobacteria synergistically release TNF-alpha and nitric oxide from macrophages via IFN-gamma induction. J. Leukoc. Biol. 68, 897-902.
26. Grohmann, U., Belladonna, M. L., Vacca, C., Bianchi, R., Fallarino, F., Orabona, C., Fioretti, M. C., Puccetti, P. (2001) Positive regulatory role of IL-12 in macrophages and modulation by IFN-γ. J. Immunol. 167, 221-227.
27. Wilkinson, K. A., Aung, H., Wu, M., Toossi, Z. (2000) Modulation of transforming growth factor beta-1 gene expression by interleukin-12. Scand. J. Immunol. 52, 271-277.
28. Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., Annette, M. H. (2000) M1/M2 macrophages and the Th1/Th2 paradigm. J. Immunol. 164, 6166-6173.
29. Buchmuller-Rouiller, Y., Mauel, J. (1986) Correlation between enhanced oxidative metabolism and leishmanicidal activity in activated macrophages from healer and nonhealer mouse strains. J. Immunol. 136, 3884-3890.
30. Liew, F. Y., Li, Y., Moss, D., Parkinson, C., Rogers, M. V., Moncada, S. (1991) Resistance to Leishmania major infection correlates with the induction of nitric oxide synthase in murine macrophages. Eur. J. Immunol. 21, 3009-3014.
31. Oswald, I. P., Afroun, S., Bray, D., Petit, J. F., Lemaire, G. (1992) Low response of BALB/c macrophages to priming and activating signals. J. Leukoc. Biol. 52, 315-322.
32. ++ and New Zealand black/white F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. J. Immunol. 161, 6878-6884.
33. Aliberti, J. C. S., Cardoso, M. A., Martins, G. A., Gazzinelli, R. T., Vieira, L. Q., Silva, J. S. (1996) Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64, 1961-1967.
34. Abrahamsohn, I. A., Coffman, R. L. (1996) Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp. Parasitol. 84, 231-244.
35. Gazzinelli, R. T., Oswald, I. P., Hieny, S., James, S. L., Sher, A. (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22, 2501-2506.
36. Ding, A., Nathan, C. F., Graycar, J., Derynck, R., Stuehr, D. J., Srimal, S. (1990) Macrophage deactivation factor and transforming growth factors-β1, β2, and -β3 inhibit induction of macrophage nitrogen oxide synthesis by IFN-γ. J. Immunol. 145, 940-944.
37. Bogdan, C., Paik, J., Vodovotz, Y., Nathan, C. (1992) Contrasting mechanisms for suppression of macrophage cytokine release by transforming growth factor-β and interleukin-10. J. Biol. Chem. 267, 23301-23308.
38. Vodovotz, Y., Bogdan, C., Paik, J., Xie, Q. W., Nathan, C. (1993) Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor β. J. Exp. Med. 178, 605-613.
39. Van Obberghen-Schilling, E., Roche, N. S., Flanders, K. C., Sporn, M. B., Roberts, A. B. (1988) Transforming growth factor beta 1 positively regulates its own expression in normal and transformed cells. J. Biol. Chem. 263, 7741-7746.
40. Erwig, L-P., Kluth, D. C., Walsh, G. M., Rees, A. J. (1998) Initial cytokine exposure determines function of macrophages and renders them unresponsive to other cytokines. J. Immunol. 161, 1983-1988.
41. Bright, J. J., Sriram, S. (1998) TGF-β inhibits IL-12-induced activation of Jak-STAT pathway in T lymphocytes. J. Immunol. 161, 1772-1777.
42. Zhang, M., Gong, J., Presky, D. H., Xue, W., Barnes, P. F. (1999) Expression of the IL-12 receptor β1 and β2 subunits in human tuberculosis. J. Immunol. 162, 2441-2447.
43. Pinson, D. M., LeClaire, R. D., Lorsbach, R. B., Parmely, M. J., Russell, S. W. (1992) Regulation by transforming growth factor-beta 1 of expression and function of the receptor for IFN-gamma on mouse macrophages. J. Immunol. 149, 2028-2034.
44. Boutard, V., Havouis, R., Fouqueray, B., Philippe, C., Moulinoux, J. P., Baud, L. (1995) Transforming growth factor-beta stimulates arginase activity in macrophages. Implications for the regulation of macrophage cytotoxicity. J. Immunol. 155, 2077-2084.